Company
Headquarters: Leederville, WA, Australia
A$1.5 Million
AUD as of Jan. 1, 2024
US$1.0 Million
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $207.62 B |
Danaher | $171.89 B |
Siemens Healthineers AG | $66.05 B |
DexCom, Inc. | $46.50 B |
IDEXX Laboratories, Inc. | $44.72 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Wellfully Limited, together with its subsidiaries, develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Singapore and Europe. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. It develops magnetic micro-array and powerless drug delivery technologies; and designs and develops drug patches, applicators, and brushes products. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Wellfully Limited has the following listings and related stock indices.
Stock: ASX: WFL wb_incandescent